[HTML][HTML] Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice
R Bella, R Kaminski, P Mancuso, WB Young… - … Therapy-Nucleic Acids, 2018 - cell.com
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso… - Molecular therapy …, 2018 - pubmed.ncbi.nlm.nih.gov
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
[HTML][HTML] Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso, WB Young… - … Therapy-Nucleic Acids, 2018 - Elsevier
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
[引用][C] Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso, WB Young… - … Therapy-Nucleic Acids, 2018 - cir.nii.ac.jp
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso, WB Young… - MOLECULAR …, 2018 - air.unimi.it
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice.
R Bella, R Kaminski, P Mancuso… - Molecular therapy …, 2018 - europepmc.org
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso… - Molecular Therapy …, 2018 - search.proquest.com
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
[HTML][HTML] Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso… - Molecular Therapy …, 2018 - ncbi.nlm.nih.gov
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso, WB Young, C Chen… - 2018 - scholarshare.temple.edu
© 2018 We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-
mediated intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating …
mediated intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating …
[PDF][PDF] Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
R Bella, R Kaminski, P Mancuso, WB Young, C Chen… - core.ac.uk
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …
intravenous delivery of CRISPR in editing the HIV-1 genome from the circulating PBMC …